Einzeltreffer — DigiBib

Background Objectives: This systematic review evaluates the human immunodeficiency virus (HIV), hepatitis C virus (HCV) and hepatitis B virus (HBV) burden among people who inject drugs (PWIDs) in India. In addition, we selectively examined research on opioid substitution treatment (OST)-related services due to their role in antiviral treatment uptake and adherence.

Methods: Data were sourced from peer-reviewed and government publications between 1991 and September 20, 2023, searched in MEDLINE, Scopus and EBSCOhost. English language studies reporting weighted prevalence or raw numbers and recruitment sites were included for review. Quality was assessed using the Joanna Briggs Institute tool. Data synthesis was done in graphs and tables.

Results: We included 50 reports, yielding 150 HIV, 68 HCV and 24 HBV prevalence estimates across India, revealing significant regional heterogeneity. Notably, 16 States had a single community-based HIV estimate, and 19 States had limited or no HCV data. The highest HIV and HCV prevalence was in Manipur (74.7% and 97.5%, respectively) in 1996. Recent spikes included 50.2 per cent HIV prevalence in Punjab (2010) and 73 per cent HCV in Uttar Pradesh (2021). Nationally, OST coverage in 2020 was under five per cent, with some northeast, north and central States exceeding this, but most others were falling below two per cent. No studies on the cost-effectiveness of directly observed treatment models for OST were identified.

Interpretation Conclusions: There is a lack of sufficiently granular and generalizable estimates for HIV prevalence and any estimates for HCV and HBV among PWIDs in large parts of the country. Community-based representative studies are required to quantify the prevalence and severity of these diseases and allocate resources.

Titel:	HIV, hepatitis B & C in people who inject drugs in India: A systematic review of regional heterogeneity & overview of opioid substitution treatment.
Autor/in / Beteiligte Person:	Shukla, L ; Shivaprakash, P ; Kumar, MS
Link:	Full Text Finder (Volltext)
Zeitschrift:	The Indian journal of medical research, Jg. 158 (2023-11-01), Heft 5&6, S. 522-534
Veröffentlichung:	<2011- > : Mumbai : Medknow ; <i>Original Publication</i>: New Delhi : Council Of Medical Research, 2023
Medientyp:	academicJournal
ISSN:	0971-5916 (print)
DOI:	10.4103/ijmr.ijmr_1930_23
Schlagwort:	Humans India epidemiology Opiate Substitution Treatment Hepatitis B virus Hepacivirus Drug Users Hepatitis B drug therapy Hepatitis B epidemiology Hepatitis C drug therapy Hepatitis C epidemiology HIV Infections drug therapy HIV Infections epidemiology
Sonstiges:	Nachgewiesen in: MEDLINE Sprachen: English Publication Type: Systematic Review; Journal Article Language: English [Indian J Med Res] 2023 Nov 01; Vol. 158 (5&6), pp. 522-534. <i>Date of Electronic Publication: </i>2024 Jan 24. MeSH Terms: Drug Users* ; Hepatitis B* / drug therapy ; Hepatitis B* / epidemiology ; Hepatitis C* / drug therapy ; Hepatitis C* / epidemiology ; HIV Infections* / drug therapy ; HIV Infections* / epidemiology ; Humans ; India / epidemiology ; Opiate Substitution Treatment ; Hepatitis B virus ; Hepacivirus References: J Neurosci Rural Pract. 2018 Jul-Sep;9(3):397-403. (PMID: 30069098) ; J Infect. 1995 Jul;31(1):49-50. (PMID: 8522832) ; Indian J Public Health. 2020 Apr;64(Supplement):S67-S70. (PMID: 32295959) ; Cochrane Database Syst Rev. 2004;(3):CD002207. (PMID: 15266465) ; Indian J Med Microbiol. 2007 Apr;25(2):174-5. (PMID: 17582199) ; Infect Genet Evol. 2017 Mar;48:156-163. (PMID: 27923769) ; AIDS Care. 2009 Nov;21(11):1420-4. (PMID: 20024719) ; BMC Health Serv Res. 2016 Nov 14;16(1):652. (PMID: 27842543) ; Indian J Psychiatry. 2021 Jul-Aug;63(4):355-365. (PMID: 34456348) ; Natl Med J India. 2001 Jul-Aug;14(4):209-11. (PMID: 11547526) ; PLoS One. 2016 Jan 26;11(1):e0147879. (PMID: 26812065) ; Indian J Med Res. 2016 Mar;143(3):348-56. (PMID: 27241649) ; Int J STD AIDS. 1998 Apr;9(4):214-8. (PMID: 9598748) ; Dig Dis Sci. 2008 May;53(5):1383-9. (PMID: 17934857) ; Int J Health Policy Manag. 2014 Aug 13;3(3):123-8. (PMID: 25197676) ; Harm Reduct J. 2017 Jun 14;14(1):38. (PMID: 28615077) ; Indian J Public Health. 2020 Apr;64(Supplement):S61-S66. (PMID: 32295958) ; Subst Use Misuse. 2010 Feb;45(3):354-67. (PMID: 20141452) ; PLoS One. 2018 Aug 30;13(8):e0203262. (PMID: 30161255) ; J Acquir Immune Defic Syndr. 2005 May 1;39(1):9-15. (PMID: 15851908) ; Asian J Psychiatr. 2019 Aug;44:58-60. (PMID: 31325758) ; Clin Infect Dis. 2021 Jul 1;73(1):e107-e118. (PMID: 32447375) ; Int J Drug Policy. 2021 Oct;96:103354. (PMID: 34247900) ; Indian J Psychiatry. 2018 Jul-Sep;60(3):361-366. (PMID: 30405267) ; Drug Alcohol Depend. 2023 Jun 1;247:109874. (PMID: 37087926) ; Public Health Rep. 1998 Jun;113 Suppl 1:58-66. (PMID: 9722810) ; Int J STD AIDS. 2014 Jul;25(8):596-606. (PMID: 24352120) ; Harm Reduct J. 2020 Sep 29;17(1):68. (PMID: 32993646) ; Harm Reduct J. 2009 Feb 26;6:4. (PMID: 19243636) ; AIDS Behav. 2013 Sep;17(7):2479-89. (PMID: 23474594) ; Int J Drug Policy. 2012 Mar;23(2):169-70. (PMID: 22280919) ; Indian J Med Res. 2008 Nov;128(5):640-6. (PMID: 19179686) ; AIDS. 1991 Jan;5(1):117-8. (PMID: 2059356) ; EClinicalMedicine. 2021 Oct 17;41:101148. (PMID: 34712928) ; Bull Narc. 1993;45(1):91-105. (PMID: 8305909) ; AIDS. 2008 Dec;22 Suppl 5:S59-68. (PMID: 19098480) ; Lancet Infect Dis. 2015 Jan;15(1):36-45. (PMID: 25486851) ; J Infect. 1991 Sep;23(2):201-7. (PMID: 1753123) ; Medicine (Baltimore). 2022 Dec 2;101(48):e31688. (PMID: 36482574) ; Int J Environ Res Public Health. 2023 May 19;20(10):. (PMID: 37239596) ; Indian J Med Microbiol. 2003 Oct-Dec;21(4):262-4. (PMID: 17643039) ; Asian Pac J Cancer Prev. 2012;13(3):799-802. (PMID: 22631651) ; Indian J Med Microbiol. 2017 Jul-Sep;35(3):332-339. (PMID: 29063876) ; Indian J Med Res. 2011 Nov;134(5):732-4. (PMID: 22199115) ; Indian J Med Microbiol. 2003 Oct-Dec;21(4):280-3. (PMID: 17643045) ; Indian J Psychiatry. 2017 Jan-Mar;59(1):6-9. (PMID: 28529353) ; Asian J Psychiatr. 2020 Mar;49:101978. (PMID: 32120298) ; Drug Alcohol Depend. 2023 May 1;246:109839. (PMID: 37031487) ; Subst Use Misuse. 2006;41(3):341-52. (PMID: 16467010) ; J Gastroenterol Hepatol. 2022 Jun;37(6):964-972. (PMID: 35263807) ; J Clin Diagn Res. 2014 Jun;8(6):DL01-2. (PMID: 25120986) ; PLoS One. 2023 Jun 15;18(6):e0287333. (PMID: 37319276) ; Indian J Psychol Med. 2022 May;44(3):246-252. (PMID: 35656428) ; BMC Public Health. 2015 Jul 30;15:726. (PMID: 26223866) ; BMC Public Health. 2022 Aug 10;22(1):1529. (PMID: 35948967) ; Lancet HIV. 2021 Sep;8(9):e544-e553. (PMID: 34331860) ; PLoS One. 2023 May 22;18(5):e0286009. (PMID: 37216389) ; Libyan J Med. 2009 Mar 01;4(1):17. (PMID: 21483496) ; Lancet HIV. 2019 May;6(5):e283-e296. (PMID: 30952565) ; J Infect. 1994 Mar;28(2):167-73. (PMID: 8034996) ; AIDS Care. 2000 Aug;12(4):497-504. (PMID: 11091782) ; AIDS. 2021 Mar 1;35(3):485-494. (PMID: 33252482) ; Indian J Sex Transm Dis AIDS. 2017 Jul-Dec;38(2):121-127. (PMID: 30148264) ; Trop Gastroenterol. 2006 Apr-Jun;27(2):80-3. (PMID: 17089617) ; Elife. 2021 Aug 03;10:. (PMID: 34342266) ; J Hepatol. 2020 Jan;72(1):67-74. (PMID: 31604081) ; Asian J Psychiatr. 2013 Feb;6(1):52-5. (PMID: 23380318) ; Scand J Infect Dis. 2014 Oct;46(10):673-7. (PMID: 25073537) ; Indian J Psychiatry. 2017 Jan-Mar;59(1):39-45. (PMID: 28529359) ; N Engl J Med. 2016 Jan 28;374(4):363-71. (PMID: 26816013) ; AIDS Res Hum Retroviruses. 2018 Apr;34(4):327-328. (PMID: 29161880) ; Addiction. 2017 Aug;112(8):1480-1487. (PMID: 28317210) ; Addict Behav. 2004 Nov;29(8):1699-705. (PMID: 15451140) ; Clin Infect Dis. 2016 Oct 15;63(8):1094-1104. (PMID: 27343545) Entry Date(s): Date Created: 20240124 Date Completed: 20240126 Latest Revision: 20240222 Update Code: 20240222 PubMed Central ID: PMC10878493

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

BibTeX Citavi, JabRef, u.a.
(Literaturverwaltung)

PDF kein Volltext!
(Merkzettel, Notizen)

RIS Endnote, Citavi u.a.
(Literaturverwaltung)

MODS
(XML zur Weiterverarbeitung)

oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

Gewünschter Zitations-Stil:

oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

HIV, hepatitis B & C in people who inject drugs in India: A systematic review of regional heterogeneity & overview of opioid substitution treatment.